arrow
W

W.H. Wilson Tang

cleveland clinic
H指数:134
被引数:10.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Continuous Vutrisiran Reduces Cardiovascular Events and Hospitalizations in Patients With Transthyretin Amyloidosis With Cardiomyopathy in the HELIOS-B One-Year Open Label Extension

连续注射Vutrisiran可降低伴心肌病的甲状腺素转运蛋白淀粉样变性患者的心血管事件和住院率:HELIO-B研究一年开放标签扩展研究

2026-10-110
OA
Gut microbiome shifts in chronic systolic heart failure are associated with disease severity and clinical improvement

慢性收缩性心力衰竭中肠道微生物组的改变与疾病严重程度和临床改善相关

2026-09-240
OA
Gut microbe-generated metabolite trimethylamine N-oxide and risk of abdominal aortic aneurysm: a cohort study

肠道菌群产生的代谢物三甲胺N-氧化物与腹主动脉瘤风险:一项队列研究

2026-07-150
PRE
Automating Chart Review Utilizing an Artificial Intelligence-Enabled System for Assessing Transthyretin Amyloid Cardiomyopathy Trial Eligibility

利用人工智能赋能系统自动化图表审查以评估转甲状腺素蛋白淀粉样变性心肌病试验的资格

2026-03-030
OAAI
Efficacy and safety evaluation of phacoemulsification with intraocular lens implantation combined with goniotomy versus combined with trabeculectomy in advanced pseudoexfoliative glaucoma with cataract

白内障超声乳化联合人工晶状体植入术,分别联合角巩膜切开术与联合小梁切除术,在伴有白内障的晚期伪剥脱性青光眼中的疗效与安全性评价

2025-12-110
PRE
P3R: Polymodal palpebral progressive refinement via symmetry aware latent diffusion for precision guided prediction of postoperative blepharoptosis morphology

P3R: 通过对称感知潜在扩散的多模态眼睑渐进细化,用于精确指导术后上睑下垂形态的预测

2025-12-030
PRE
REPLY

回复

2025-12-010
PRE